109 related articles for article (PubMed ID: 26269136)
21. Effect of Cyclophosphamide Treatment on Central and Effector Memory T Cells in Mice.
Włodarczyk M; Ograczyk E; Kowalewicz-Kulbat M; Druszczyńska M; Rudnicka W; Fol M
Int J Toxicol; 2018; 37(5):373-382. PubMed ID: 29923437
[TBL] [Abstract][Full Text] [Related]
22. A requirement for helper T cells in the induction of delayed-type hypersensitivity.
Wright K; Ramshaw IA
J Immunol; 1983 Apr; 130(4):1596-9. PubMed ID: 6187816
[TBL] [Abstract][Full Text] [Related]
23. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
24. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice.
Shim JY; Han Y; Ahn JY; Yun YS; Song JY
Int J Immunopathol Pharmacol; 2007; 20(3):487-97. PubMed ID: 17880762
[TBL] [Abstract][Full Text] [Related]
25. Phyllanthin from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb/C mice.
Ilangkovan M; Jantan I; Bukhari SN
Phytomedicine; 2016 Nov; 23(12):1441-1450. PubMed ID: 27765364
[TBL] [Abstract][Full Text] [Related]
26. Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel ML
J Chemother; 2004 Apr; 16(2):187-92. PubMed ID: 15216955
[TBL] [Abstract][Full Text] [Related]
27. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313
[TBL] [Abstract][Full Text] [Related]
28. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
29. Early events in peripheral regulatory T cell induction via the nasal mucosa.
Unger WW; Hauet-Broere F; Jansen W; van Berkel LA; Kraal G; Samsom JN
J Immunol; 2003 Nov; 171(9):4592-603. PubMed ID: 14568933
[TBL] [Abstract][Full Text] [Related]
30. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
Mayumi H; Good RA
J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
[TBL] [Abstract][Full Text] [Related]
31. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.
Diamantstein T; Klos M; Hahn H; Kaufmann SH
J Immunol; 1981 May; 126(5):1717-9. PubMed ID: 6452475
[TBL] [Abstract][Full Text] [Related]
32. [Immunodepressant action of cyclophosphamide in different strains of mice].
Pevnitskiĭ LA; Telegin LIu; Bol'shev VN
Biull Eksp Biol Med; 1977 Apr; 83(4):438-40. PubMed ID: 558023
[TBL] [Abstract][Full Text] [Related]
33. Effects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model.
Chen HS; Chen J; Cui DL; Zheng YY; Xu AH; Chen G; Jia LC
World J Gastroenterol; 2007 Dec; 13(48):6575-80. PubMed ID: 18161930
[TBL] [Abstract][Full Text] [Related]
34. Lactobacillus plantarum HY7712 ameliorates cyclophosphamide-induced immunosuppression in mice.
Jang SE; Joh EH; Lee HY; Ahn YT; Lee JH; Huh CS; Han MJ; Kim DH
J Microbiol Biotechnol; 2013 Mar; 23(3):414-21. PubMed ID: 23462016
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of T-suppressors responsible for the competition between cellular and humoral immune response in the spleen].
Gusev EIu; Kevorkov NN
Biull Eksp Biol Med; 1993 Mar; 115(3):287-9. PubMed ID: 8054627
[TBL] [Abstract][Full Text] [Related]
36. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
[TBL] [Abstract][Full Text] [Related]
37. Immunotoxic effects of imidacloprid following 28 days of oral exposure in BALB/c mice.
Badgujar PC; Jain SK; Singh A; Punia JS; Gupta RP; Chandratre GA
Environ Toxicol Pharmacol; 2013 May; 35(3):408-18. PubMed ID: 23467117
[TBL] [Abstract][Full Text] [Related]
38. Effect of Ajuga bracteosa on systemic T-cell immunity in Balb/C mice: dual Th1/Th2 immunostimulatory effects.
Nisar A; Akhtar N; Hassan A; Banday T; Wani B; Zargar MA
Am J Chin Med; 2014; 42(2):375-92. PubMed ID: 24707869
[TBL] [Abstract][Full Text] [Related]
39. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells.
Zhang QW; Mayumi H; Umesue M; Tomita Y; Nomoto K; Yasui H
Transplantation; 1997 Jun; 63(11):1667-73. PubMed ID: 9197364
[TBL] [Abstract][Full Text] [Related]
40. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
